BVF Partners L P/il, Director, 10% Owner at MoonLake Immunotherapeutics (MLTX), sold 3,750,000 shares at $16.79 ($63.0M) on 2026-03-31, disclosed to the SEC on 2026-04-02.
Open-market sale of $63.0M MLTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.79 | 248,530 | $4.2M | 6.6% |
| 2 | $16.79 | 1,569,116 | $26.3M | 41.8% |
| 3 | $16.79 | 1,932,354 | $32.4M | 51.5% |
| Total | $16.79 avg | 3,750,000 | $63.0M | 100% |
| Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |
| XOMA | BUY | 2020-03-17 | $2.4M | — | Filing → |